4.6 Article

Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door

Bijo Mathew et al.

Summary: The use of halogens in drug structures plays a significant role in modulating their physical-chemical properties and enzymatic selectivity, especially through the formation of halogen bonds at active sites. This review highlights the impact of halogens on Monoamine Oxidase activity and isozyme selectivity.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Revealing the role of fluorine pharmacophore in chalcone scaffold for shifting the MAO-B selectivity: investigation of a detailed molecular dynamics and quantum chemical study

Fisayo A. Olotu et al.

Summary: The development of highly selective monoamine oxidase-B (MAO-B) inhibitors has shown great therapeutic potential in treating various neurodegenerative disorders. Recent research has highlighted the significant impact of the position and orientation of fluorine atoms on the selectivity of three compounds in MAO-B inhibition, providing a novel direction for the development of fluorinated chalcones for neurodegenerative disorder treatment.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Chemistry, Medicinal

Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-Thiazole derivatives with anti-inflammatory activities for the treatment of sepsis

Zhen Zhang et al.

Summary: In this study, a novel compound E26 was designed and synthesized to treat sepsis by inhibiting inflammatory response. Experimental results demonstrated that compound E26 exhibited potent anti-inflammatory activity by suppressing the production of various inflammatory factors through blocking the MAPKs signaling pathway, and showed significant efficacy in a mouse model of sepsis.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence

Bahare Salehi et al.

Summary: Chalcones and their derivatives have shown a wide range of biological activities in preclinical and clinical studies, including anticancer, anti-inflammatory, antimicrobial, and antioxidant effects. They have potential in treating chronic venous insufficiency, skin conditions, and cancer, with further research needed to understand their bioavailability, toxicity concerns, and mode of action.

FRONTIERS IN PHARMACOLOGY (2021)

Article Environmental Sciences

Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders

Bijo Mathew et al.

Summary: The study evaluated eleven piperazine-containing derivatives for their inhibitory activities against MAOs, ChEs, and BACE-1, with compounds PC10 and PC11 showing significant inhibitory effects on MAO-B. Compound PC3 effectively inhibited BACE-1, suggesting that PC10 and PC11 could be potential candidates for the treatment of neurological disorders.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)

Article Chemistry, Multidisciplinary

Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors

Nisha Abdul Rehuman et al.

Summary: A series of halogenated coumarin-chalcones were synthesized and evaluated for their inhibitory activities against several enzymes. Compound CC2 showed potent inhibition of MAO-B with high selectivity, as well as competitive inhibition of BChE. These compounds have the potential to be drug candidates for neurodegenerative disorders.

ACS OMEGA (2021)

Article Chemistry, Medicinal

Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B

Luca G. Iacovino et al.

Summary: A library of monosubstituted chalcones with electron-donating and electron-withdrawing groups on aromatic rings was selected for evaluation. Compounds 13 and 14 were found to inhibit MAO-B and may be worth considering as novel MAO-B-selective inhibitors for neurodegenerative disease treatment.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Pharmacology & Pharmacy

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders

Vishal Payyalot Koyiparambath et al.

Summary: Six halogenated trimethoxy chalcone derivatives were synthesized and evaluated for their inhibitory potential against MAOs and BACE-1. Compounds CH4 and CH5 showed strong inhibition of MAO-B, exhibited protective effects on VERO cells, and had high blood brain barrier permeabilities.

PHARMACEUTICS (2021)

Review Biochemical Research Methods

Treatment of Parkinson's Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review

Della G. T. Parambi

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

Review Biochemical Research Methods

A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Poteneies

Nisha A. Rehuman et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

Review Chemistry, Medicinal

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors

Paolo Guglielmi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Editorial Material Biochemical Research Methods

Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery

Bijo Mathew et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

Review Pharmacology & Pharmacy

Recent developments in biological aspects of chalcones: the odyssey continues

Anu Rani et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Review Neurosciences

Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review

Bijo Mathew et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2019)

Review Chemistry, Medicinal

Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update

Rati Kailash Prasad Tripathi et al.

MEDICINAL RESEARCH REVIEWS (2019)

Review Clinical Neurology

90years of monoamine oxidase: some progress and some confusion

Keith F. Tipton

JOURNAL OF NEURAL TRANSMISSION (2018)

Review Biochemistry & Molecular Biology

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Jianhua Zhang et al.

JOURNAL OF NEUROCHEMISTRY (2018)

Review Neurosciences

The Emerging Evidence of the Parkinson Pandemic

E. Ray Dorsey et al.

JOURNAL OF PARKINSONS DISEASE (2018)

Article Clinical Neurology

Parkinson's: a syndrome rather than a disease?

Nataliya Titova et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Review Clinical Neurology

Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature

Susanne A. Schneider et al.

MOVEMENT DISORDERS (2017)

Article Multidisciplinary Sciences

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function

N. Plotegher et al.

SCIENTIFIC REPORTS (2017)

Review Neurosciences

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Livia Dezsi et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)

Review Chemistry, Multidisciplinary

Chalcone: A Privileged Structure in Medicinal Chemistry

Chunlin Zhuang et al.

CHEMICAL REVIEWS (2017)

Article Chemistry, Medicinal

Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors

Arwa Hammuda et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in Parkinson's disease

Anindita Bose et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Review Chemistry, Medicinal

Recent developments in biological activities of chalcones: A mini review

Parvesh Singh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Selected furanochalcones as inhibitors of monoamine oxidase

Sarel J. Robinson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Chalcones: A Valid Scaffold for Monoamine Oxidases Inhibitors

Franco Chimenti et al.

JOURNAL OF MEDICINAL CHEMISTRY (2009)

Review Clinical Neurology

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

Dennis W. Dickson et al.

LANCET NEUROLOGY (2009)

Review Clinical Neurology

Parkinson's disease: clinical features and diagnosis

J. Jankovic

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Multidisciplinary Sciences

Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors

Se-Young Son et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Neurosciences

The therapeutic potential of monoamine oxidase inhibitors

MBH Youdim et al.

NATURE REVIEWS NEUROSCIENCE (2006)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)